PMID: 15557326

Ozvegy-Laczka C, Varady G, Koblos G, Ujhelly O, Cervenak J, Schuetz JD, Sorrentino BP, Koomen GJ, Varadi A, Nemet K, Sarkadi B
Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface.
J Biol Chem. 2005 Feb 11;280(6):4219-27. Epub 2004 Nov 22., 2005-02-11 [PubMed]
Sentences
No. Mutations Sentence Comment
5 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:5:83
status: VERIFIED
view ABCG2 p.Lys86Met details
The binding of the 5D3 antibody to a non-functional ABCG2 catalytic center mutant (K86M) in intact cells was not affected by the addition of vanadate but still increased with the addition of Ko143. Login to comment
8 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:8:34
status: VERIFIED
view ABCG2 p.Lys86Met details
In membranes expressing the ABCG2-K86M mutant, ATP, ADP, and AMP-PNP decreased, whereas Ko143 increased 5D3 binding. Login to comment
53 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:53:46
status: VERIFIED
view ABCG2 p.Lys86Met details
Sf9 cells expressing the ABCG2 protein or its K86M variant were prepared as described previously (31). Login to comment
54 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 15557326:54:141
status: VERIFIED
view ABCG2 p.Arg482Gly details
ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:54:33
status: VERIFIED
view ABCG2 p.Lys86Met details
ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:54:136
status: VERIFIED
view ABCG2 p.Lys86Met details
In the present study we used the K86M variant introduced into the wild-type (R482) ABCG2 by cloning the NotI-SpeI fragment of pAcUW21-L/K86M-R482G (31) into the corresponding site of the pAcUW21-L/R482 vector. Login to comment
83 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:83:81
status: VERIFIED
view ABCG2 p.Lys86Met details
ATPase Activity Measurement-Sf9 membranes containing human ABCG2, MDR1, or ABCG2-K86M were harvested, and their membranes were isolated and stored at -80 °C according to Sarkadi et al. (34, 35). Login to comment
92 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:92:59
status: VERIFIED
view ABCG2 p.Lys86Met details
Panel A shows expression of human, wild-type ABCG2, or the K86M-ABCG2 variant in isolated membranes of Sf9 insect cells (11). Login to comment
93 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:93:118
status: VERIFIED
view ABCG2 p.Lys86Met details
Panel B shows BXP-21 immunoreactions with cell lysates of PLB cells, engineered to express the wild-type ABCG2 or its K86M mutant variant. Login to comment
94 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:94:28
status: VERIFIED
view ABCG2 p.Lys86Met details
The expression level of the K86M variant of ABCG2 was about one-third the expression obtained for the wild-type protein (these cells could not be selected by mitoxantrone; see "Experimental Procedures" and Ozvegy et al. (31)). Login to comment
110 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:110:41
status: VERIFIED
view ABCG2 p.Lys86Met details
ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:110:204
status: VERIFIED
view ABCG2 p.Lys86Met details
Sf9 membranes containing WT ABCG2, ABCG2-K86M, or beta-galactosidase (beta-gal, panel A) and cell lysates from PLB (panel B), HEK 293 (panel C), and MCF-7/MX (panel D) cells expressing WT ABCG2 (or ABCG2-K86M) or parental cells (ctr.) Login to comment
131 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:131:76
status: VERIFIED
view ABCG2 p.Lys86Met details
There was no effect of 5D3 antibody on the ATPase activity of MDR1 or ABCG2-K86M membranes. Login to comment
146 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:146:41
status: VERIFIED
view ABCG2 p.Lys86Met details
Sf9 membranes containing WT ABCG2, ABCG2-K86M, or MDR1 were incubated with 20 (low 5D3, hatched columns) or 160 ␮g (high 5D3, black columns)/mg membrane concentration of 5D3 antibody. Login to comment
161 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 15557326:161:104
status: VERIFIED
view ABCG2 p.Arg482Gly details
We obtained essentially similar data in the MCF-7/MX cells and the PLBs expressing the gain-of-function R482G mutant of ABCG2 (not shown). Login to comment
182 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:182:101
status: VERIFIED
view ABCG2 p.Lys86Met details
ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:182:240
status: VERIFIED
view ABCG2 p.Lys86Met details
Effects of Substrates, Inhibitors, and ATP Depletion on 5D3 Reactivity in the Mutant, Non-functional K86M-ABCG2, Expressed in Intact Cells-In the next set of experiments we studied intact mammalian cells expressing a non-functional mutant (K86M) variant of ABCG2. Login to comment
184 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:184:41
status: VERIFIED
view ABCG2 p.Lys86Met details
As shown in Fig. 6, panels A and B, this K86M-ABCG2 had no MX extrusion function but showed a well measurable 5D3 binding on the cell surface. Login to comment
185 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:185:54
status: VERIFIED
view ABCG2 p.Lys86Met details
In these studies we found that the 5D3 binding of the K86M mutant ABCG2 was significantly increased by PFA fixation, ATP depletion, or Ko143 treatment. Login to comment
187 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:187:25
status: VERIFIED
view ABCG2 p.Lys86Met details
Thus, the non-functional K86M variant of ABCG2 showed a relatively high 5D3 binding in its native state, but in the case of ATP removal and Ko143 treatment, similar conformational changes were detected by 5D3 in this mutant variant as in the wild-type protein. Login to comment
188 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:188:68
status: VERIFIED
view ABCG2 p.Lys86Met details
The lack of the formation of a transition-state intermediate in the K86M-ABCG2 correlated with the absence of an effect of sodium orthovanadate. Login to comment
189 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:189:253
status: VERIFIED
view ABCG2 p.Lys86Met details
Effects of Nucleotides and Transport Inhibitors on 5D3 Reactivity of ABCG2 in Isolated Membrane Fragments-In the following experiments we examined the effects of various nucleotides and transport inhibitors on 5D3 binding by human ABCG2 and its mutant (K86M) variant in isolated insect cell membrane fragments. Login to comment
194 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:194:99
status: VERIFIED
view ABCG2 p.Lys86Met details
Fig. 7, B and C, documents the effects of various ligands on 5D3 binding to wild-type (panel B) or K86M (panel C) ABCG2 in isolated membranes. Login to comment
209 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:209:72
status: VERIFIED
view ABCG2 p.Lys86Met details
Fig. 7, panel C, shows 5D3 binding in isolated membranes containing the K86M, non-functional mutant ABCG2 protein. Login to comment
213 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:213:137
status: VERIFIED
view ABCG2 p.Lys86Met details
These data can be interpreted to mean that although MgAMP does not show binding to the protein, MgATP, MgADP, and MgAMP-PNP are bound to K86M-ABCG2, and in the absence of a full catalytic cycle, they fix the transporter in a nucleotide-bound, reduced 5D3 binding state. This fixation does not require the presence of vanadate. Login to comment
215 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:215:45
status: VERIFIED
view ABCG2 p.Lys86Met details
Interestingly, Ko143 can still stabilize the K86M-ABCG2 variant in a high 5D3 binding state. Login to comment
220 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:220:63
status: VERIFIED
view ABCG2 p.Lys86Met details
These effects were similar both in the wild-type ABCG2 and the K86M mutant variant (not documented in detail). Login to comment
237 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:237:259
status: VERIFIED
view ABCG2 p.Lys86Met details
In the present experiments the arrest of the ABCG2 transport cycle by Ko143 by the removal of the energy donor substrate, ATP, as well as by sodium orthovanadate was documented by the lack of active MX extrusion in the FIG. 6. Flow cytometry detection of the K86M-ABCG2 protein. Login to comment
238 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:238:56
status: VERIFIED
view ABCG2 p.Lys86Met details
5D3 mAb binding (panel A) and MX extrusion (panel B) in K86M mutant ABCG2-expressing intact PLB cells is shown. Login to comment
250 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:250:114
status: VERIFIED
view ABCG2 p.Lys86Met details
When examining the binding of the 5D3 antibody in intact cells to a non-functional ABCG2 catalytic center mutant (K86M-ABCG2), we found that 5D3 binding to this mutant protein was also efficient. Login to comment
259 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:259:7
status: VERIFIED
view ABCG2 p.Lys86Met details
In the K86M-ABCG2 variant the addition of MgATP, MgADP, and MgAMP-PNP all caused a major reduction of 5D3 binding, which was not further modulated by sodium orthovanadate. Login to comment
263 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:263:73
status: VERIFIED
view ABCG2 p.Lys86Met details
Interestingly, in Sf9 membranes containing either wild-type ABCG2 or its K86M mutant in the absence of Mg2ϩ (that is, in the presence of EDTA), ATP, ADP, and AMP-PNP caused a decrease in 5D3 binding (not shown in detail). Login to comment
270 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:270:85
status: VERIFIED
view ABCG2 p.Lys86Met details
Isolated membrane fragments (45 ␮g) from Sf9 cells containing WT ABCG2, ABCG2-K86M, or MDR1 were labeled with 1 ␮g/ml 5D3 (black columns) or 1 ␮g/ml mouse IgG2b as isotype control (white columns). Login to comment
273 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:273:45
status: VERIFIED
view ABCG2 p.Lys86Met details
Panel C, 5D3 binding to membranes containing K86M mutant ABCG2. Login to comment
274 ABCG2 p.Lys86Met
X
ABCG2 p.Lys86Met 15557326:274:54
status: VERIFIED
view ABCG2 p.Lys86Met details
Sf9 membranes containing wild-type ABCG2 (panel B) or K86M mutant ABCG2 (panels C) were incubated with 5D3 antibody in the presence of 10 mM MgAMP, MgADP, MgATP, MgAMP-PNP, MgAMP plus 2 mM vanadate, MgATP plus 2 mM vanadate, MgATP plus 2 mM vanadate plus 1 ␮M Ko143, MgADP plus 1 ␮M Ko143, MgATP plus 1 ␮M Ko143, or 10 mM MgAMP-PNP plus 1 ␮M Ko143. Login to comment